“…7 Thus, although drug-eluting stents (DES) vs. bare metal stents (BMS) have shown better outcomes in the treatment of native coronary artery disease, 5 most major studies excluded or had few patients with SVG lesions, and studies comparing DES vs. BMS in SVG interventions have yielded conflicting results, and most of them do not have long-term follow-up. 2,[7][8][9][10] The article by Collet et al 11 published in this issue of the Revista Brasileira de Cardiologia Invasiva provides additional insights into the comparison of DES vs. BMS for the treatment of SVGs, using data from a Registry that included consecutive patients enrolled and divided according to the type of stent deployed (209 with DES and 99 with BMS). The rationale of this study is this lack of large studies with long-term follow-up (> 1 year).…”